Urect Tablet 0.5 mg (Rasagiline Mesylate)

Adult dose

This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If it is well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1 mg once daily. This drug may be taken with or without food.

This medication should not be used in patients who are allergic to its active ingredient or any other components. Patients who are taking or have recently discontinued other MAO inhibitors or certain herbal medications should not take this medication. Furthermore, this medication should not be administered to patients who are taking or have stopped certain drugs such as pethidine, tramadol, or dextromethorphan within the last 2 weeks. Patients with moderate to severe hepatic impairment should not use this medication, and caution should be exercised in patients with mild liver dysfunction. During treatment with this medication, various side effects such as infections, skin abnormalities, blood disorders, psychiatric symptoms, neurological symptoms, cardiac and respiratory issues, and gastrointestinal disorders may occur. Particularly, symptoms like dizziness, headache, nausea, insomnia, musculoskeletal pain, joint pain, and fever are commonly reported. If any unusual symptoms occur, immediate consultation with a physician is necessary. This medication may worsen psychiatric symptoms such as hallucinations or confusion in patients with Parkinson's disease; hence caution is required. Additionally, blood pressure elevation or hypotension, and behavioral changes such as impulse control disorders may occur, necessitating regular monitoring. Occasionally, sudden drowsiness or sleep attacks may occur during daytime, so caution should be exercised when driving or operating machinery. This medication has many interactions with other drugs; thus, it should not be taken with other MAO inhibitors, certain analgesics, antidepressants, or sympathomimetics. Patients must inform healthcare providers of any medications they are currently taking. Caution is required for pregnant or breastfeeding women using this medication, and its safety has not been established in pediatric patients. Overdosage can lead to severe side effects; therefore, the prescribed dosage must be adhered to, and in case of overdose, the patient should seek immediate medical treatment. Finally, this medication should be stored out of the reach of children, away from direct sunlight, and at a temperature between 1 to 25 degrees Celsius.

• Influenza
• skin cancer
• leukopenia
• allergy
• appetite loss
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to avoid exposure to air or humidity. It is advisable to maintain a storage temperature between 1 and 25 degrees Celsius. This will help preserve the medication's efficacy.

Appearance

White round tablet

Package unit

30 tablets/PTP[[10 tablets/PTP*3]]